Grünenthal has moved its painkiller resiniferatoxin into phase 3 trials in patients with osteoarthritis, hoping to find an option that sidesteps the side effects and addictive potential of opioid ...

Sanofi is preparing a phase 3 programme for asthma candidate amlitelimab, despite mixed data in a phase 2 trial.

Reuters.com is your online source for the latest China news stories and current events, ensuring our readers up to date with any breaking news developments ...

Stay up-to-date on Target Corporation Common Stock (TGT) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule.